Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ananda PharmaSTU:1FX FCF Margin % is 0.00% as of Jul. 2025. The stock has 5 warning signs investors should review. Among 961 Drug Manufacturers companies, Ananda Pharma ranks worse than 99.27% on this metric.
The historical rank and industry rank for Ananda Pharma's FCF Margin % or its related term are showing as below:
STU:1FX'
s FCF Margin % Range Over the Past 10 Years
Min: -81600 Med: -81600 Max: -16233.33
Current: -16233.33
During the past 7 years, the highest FCF Margin % of Ananda Pharma was -16233.33%. The lowest was -81600.00%. And the median was -81600.00%.
STU:1FX's FCF Margin % is ranked worse than 99.27% of 961
companies
in the Drug Manufacturers industry
Industry Median: 2.59
vs STU:1FX: -16233.33
Ananda Pharma FCF Margin % Related Terms
Ananda Pharma FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ananda Pharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:1FX vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ananda Pharma FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ananda Pharma's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ananda Pharma (STU:1FX) has a FCF Margin % of 0.00% as of Jul. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ananda Pharma and its competitors. According to the industry distribution chart, Ananda Pharma ranks #954 out of 961 companies in the Drug Manufacturers industry, placing it in the top 99.3%.
Is Ananda Pharma's FCF Margin % too high?
Ananda Pharma's current FCF Margin % is 0.00%. Based on the distribution chart, Ananda Pharma ranks #954 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Ananda Pharma's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ananda Pharma ranks #954 out of 961 companies for FCF Margin %. This places Ananda Pharma in the lower half of its industry. The industry median FCF Margin % is 2.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.59, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ananda Pharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ananda Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (STU:1FX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ananda Pharma (STU:1FX), the current FCF Margin % is 0.00% as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1FX has been successfully added to your 
